Dong-Kug Choi has been appointed as a Professor at the Department of Integrated Bioscience, Konkuk University, Korea. He finished his Ph.D. degree (1999) in molecular medicine at the Human Genome Center, University of Tokyo, Tokyo, Japan, and then finished postdoctoral training at Columbia University and Cornell University, New York, USA, respectively. Currently, Choi's group works on the role of different receptors such as the nuclear receptors, G-Protein-coupled receptors, and glutamate receptors, as the therapeutic target for neurodegenerative diseases by utilizing cell culture models, transgenic animal models, and neurotoxic agent-induced animal models. He has authored over 190 publications with total citations of 10,000. His particular interests include finding therapeutic targets and molecules for treating neurodegenerative disease based on the pathophysiological and pharmacological correlation.